Stock data
OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR) reported net income of -US$59.52M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$62.95M | -US$59.52M | — |
| 2024 | US$0.00M | — | -US$54.39M | -US$52.67M | — |
| 2023 | — | — | -US$36.93M | -US$35.31M | — |
| 2022 | — | — | -US$53.85M | -US$51.95M | — |
| 2021 | — | — | -US$39.82M | -US$39.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$15.35M | — |
| 2026-03-31 | — | -US$15.16M | — |
| 2025-12-31 | — | -US$13.50M | — |
| 2025-09-30 | — | -US$14.70M | — |
| 2025-06-30 | — | -US$15.39M | — |
| 2025-03-31 | — | -US$15.93M | — |
| 2024-12-31 | — | -US$17.44M | — |
| 2024-09-30 | — | -US$11.56M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.